FDA Approved: TOLVAPTAN — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s Abbreviated New Drug Application for tolvaptan, creating a generic version of the vasopressin V2 receptor antagonist.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)